Allergy Therapeutics plc
AGY.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£29,047 | -£11,085 | -£24,565 | -£7,826 |
| Dep. & Amort. | £2,237 | £1,935 | £2,205 | £2,114 |
| Deferred Tax | £0 | £0 | £0 | -£4,967 |
| Stock-Based Comp. | £0 | £0 | £0 | £351 |
| Change in WC | -£570 | -£2,764 | £81 | -£388 |
| Other Non-Cash | £6,292 | £4,285 | £425 | -£59 |
| Operating Cash Flow | -£21,088 | -£7,629 | -£21,854 | -£10,774 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£1,898 | -£1,524 | -£1,536 | -£1,865 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £267 | £0 | £2,067 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | £69 |
| Investing Cash Flow | -£1,631 | -£1,524 | £531 | -£1,796 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £34,415 | -£461 | £60,640 | -£26,742 |
| Stock Issued | £0 | £0 | -£38,376 | £39,731 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£20,183 | £18,269 | -£1,461 | -£1,805 |
| Financing Cash Flow | £14,232 | £17,808 | £20,803 | £11,184 |
| Forex Effect | -£399 | £106 | -£87 | £63 |
| Net Chg. in Cash | -£8,886 | £8,761 | -£607 | -£1,323 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £21,676 | £12,915 | £13,522 | £14,845 |
| End Cash | £12,790 | £21,676 | £12,915 | £13,522 |
| Free Cash Flow | -£22,828 | -£9,153 | -£23,390 | -£12,639 |